WO2005087793A3 - Immunostimulatory compositions and uses thereof - Google Patents

Immunostimulatory compositions and uses thereof Download PDF

Info

Publication number
WO2005087793A3
WO2005087793A3 PCT/US2005/003766 US2005003766W WO2005087793A3 WO 2005087793 A3 WO2005087793 A3 WO 2005087793A3 US 2005003766 W US2005003766 W US 2005003766W WO 2005087793 A3 WO2005087793 A3 WO 2005087793A3
Authority
WO
WIPO (PCT)
Prior art keywords
immunostimulatory compositions
immunostimulatory
compositions
identification
methods
Prior art date
Application number
PCT/US2005/003766
Other languages
French (fr)
Other versions
WO2005087793A2 (en
Inventor
Laura L Eggink
Valerie Jacobs
J Kenneth Hoober
Original Assignee
Univ Arizona State
Laura L Eggink
Valerie Jacobs
J Kenneth Hoober
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona State, Laura L Eggink, Valerie Jacobs, J Kenneth Hoober filed Critical Univ Arizona State
Priority to US10/588,627 priority Critical patent/US8034773B2/en
Publication of WO2005087793A2 publication Critical patent/WO2005087793A2/en
Publication of WO2005087793A3 publication Critical patent/WO2005087793A3/en
Priority to US13/270,010 priority patent/US10093712B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

The present invention provides novel immuno-stimulatory polypeptides, and methods for their use and identification.
PCT/US2005/003766 2004-02-05 2005-02-04 Immunostimulatory compositions and uses thereof WO2005087793A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/588,627 US8034773B2 (en) 2004-02-05 2005-02-04 Immunostimulatory compositions and uses thereof
US13/270,010 US10093712B2 (en) 2004-02-05 2011-10-10 Immunostimulatory compositions and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54219804P 2004-02-05 2004-02-05
US60/542,198 2004-02-05
US63382504P 2004-12-07 2004-12-07
US60/633,825 2004-12-07

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/588,627 A-371-Of-International US8034773B2 (en) 2004-02-05 2005-02-04 Immunostimulatory compositions and uses thereof
US13/270,010 Continuation US10093712B2 (en) 2004-02-05 2011-10-10 Immunostimulatory compositions and uses thereof

Publications (2)

Publication Number Publication Date
WO2005087793A2 WO2005087793A2 (en) 2005-09-22
WO2005087793A3 true WO2005087793A3 (en) 2006-06-29

Family

ID=34971742

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/003766 WO2005087793A2 (en) 2004-02-05 2005-02-04 Immunostimulatory compositions and uses thereof

Country Status (2)

Country Link
US (2) US8034773B2 (en)
WO (1) WO2005087793A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034773B2 (en) 2004-02-05 2011-10-11 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
US8178649B2 (en) 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US8496942B2 (en) 2006-12-13 2013-07-30 Susavion Biosciences, Inc. Therapeutic peptides and uses thereof
US7811995B2 (en) * 2006-12-13 2010-10-12 Susavion Biosciences, Inc. Therapeutic and diagnostic peptides
US8460697B2 (en) 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
WO2011027308A1 (en) * 2009-09-03 2011-03-10 Koninklijke Philips Electronics N.V. Novel tumor markers
EP2694088B1 (en) * 2011-04-07 2017-06-07 Efranat Ltd. Macrophage activating factor for pharmaceutical compositions
WO2013130953A2 (en) * 2012-03-01 2013-09-06 The Trustees Of Columbia University In The City Of New York Autism-associated biomarkers and uses thereof
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
ES2781673T3 (en) * 2014-12-19 2020-09-04 Susavion Biosciences Inc Immunotherapy treatments and compositions
US10350260B2 (en) * 2015-04-27 2019-07-16 Susavion Biosciences, Inc. Compositions and methods for treating cancer and persistent viral infections
JP6740250B2 (en) * 2015-04-27 2020-08-12 スサヴィオン バイオサイエンシーズ インコーポレイテッド Compositions and methods for treating cancer and persistent viral infections
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040903A1 (en) * 1995-06-07 1996-12-19 Nobuto Yamamoto Macrophage activating factors derived from cloned vitamin d binding protein
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
WO2000031130A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
WO2002058589A2 (en) * 2000-11-09 2002-08-01 Northeastern Ohio Universities College Of Medicine Agents and methods for promoting bone growth
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753481A (en) * 1993-03-08 1998-05-19 Fujisawa Pharmaceutical Co., Ltd. L-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from gluconobacter oxydans T-100
DE4407489A1 (en) * 1994-03-07 1995-09-14 Bayer Ag Vaccine for the prevention of respiratory and reproductive diseases of the pig
US6489541B1 (en) * 1994-06-24 2002-12-03 Michigan State University Board Of Trustees Genetic control of plant hormone levels and plant growth
EP1013764A1 (en) * 1994-07-05 2000-06-28 Steeno Research Group A/S Immunomodulators
US5677276A (en) * 1994-12-23 1997-10-14 La Jolla Cancer Research Foundation Immobilization of peptides to hyaluronate
US5891994A (en) * 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
GB9714680D0 (en) * 1997-07-11 1997-09-17 Medical Res Council Recombinant production of proteins
US6180343B1 (en) * 1998-10-08 2001-01-30 Rigel Pharmaceuticals, Inc. Green fluorescent protein fusions with random peptides
US7105481B2 (en) * 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
CA2290722A1 (en) 1999-12-08 2001-06-08 Glen C. Macdonald Consensus peptide presenting entities
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US7202226B2 (en) * 2000-10-23 2007-04-10 Detroit R & D Augmentation of wound healing by elF-4E mRNA and EGF mRNA
GB0112126D0 (en) * 2001-05-18 2001-07-11 Allergene Inc Composition
WO2003061589A2 (en) * 2002-01-23 2003-07-31 Cel-Sci Corporation Methods for treating diseases or conditions with peptide constructs
WO2003062271A1 (en) * 2002-01-25 2003-07-31 The University Court Of The University Of Aberdeen Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
AU2003220188A1 (en) * 2002-03-11 2003-09-29 President And Fellows Of Harvard College Detection and quantification of modified proteins
EP1499729B9 (en) * 2002-04-18 2012-03-14 Yeda Research And Development Co., Ltd. Derivatives of the nf-kappab inducing enzyme, their preparation and use
US7553926B2 (en) 2002-04-23 2009-06-30 Andrea Savarino Compositions containing anti-HIV peptides and methods for use
CN1650012A (en) 2002-07-24 2005-08-03 英特塞尔股份公司 Antigens encoded by alternative reading frame from pathogenic viruses
AU2003295422B2 (en) * 2002-11-07 2009-01-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services A new target for angiogenesis and anti-angiogenesis therapy
ATE500320T1 (en) * 2003-08-18 2011-03-15 Amsterdam Inst Of Viral Genomics B V CORONAVIRUS, NUCLEIC ACID, PROTEIN, METHOD FOR GENERATING VACCINES, MEDICATIONS AND DIAGNOSTICS
US20050063937A1 (en) * 2003-09-16 2005-03-24 Cheng Li Multiple-arm peptide compounds, methods of manufacture and use in therapy
US8034773B2 (en) 2004-02-05 2011-10-11 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
CA2574572A1 (en) * 2004-07-19 2006-10-26 Baylor College Of Medicine Modulation of cytokine signaling regulators and applications for immunotherapy
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
DK1866339T3 (en) 2005-03-25 2013-09-02 Gitr Inc GTR-binding molecules and their applications
BRPI0613284A2 (en) * 2005-06-17 2010-12-28 Genentech Inc acceleration methods of wound healing
WO2007062060A2 (en) * 2005-11-22 2007-05-31 Ted Reid Methods and compositions using substance p to promote wound healing

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
WO1996040903A1 (en) * 1995-06-07 1996-12-19 Nobuto Yamamoto Macrophage activating factors derived from cloned vitamin d binding protein
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
WO2000031130A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
WO2002058589A2 (en) * 2000-11-09 2002-08-01 Northeastern Ohio Universities College Of Medicine Agents and methods for promoting bone growth

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE PSIPS [online] USPTO; 18 October 2005 (2005-10-18), XP002349772, retrieved from HTTP://SEQDATA.USPTO.GOV/?PAGEREQUEST=VIEWSEQUENCE&DOCID=06551795&SEQID=27024 *

Also Published As

Publication number Publication date
WO2005087793A2 (en) 2005-09-22
US20090041793A1 (en) 2009-02-12
US8034773B2 (en) 2011-10-11
US20120108521A1 (en) 2012-05-03
US10093712B2 (en) 2018-10-09

Similar Documents

Publication Publication Date Title
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
WO2006066024A3 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2006017538A3 (en) Hk1-binding proteins
WO2007014930A3 (en) Polyammonium/polysiloxane copolymers
WO2008121767A3 (en) Stitched polypeptides
WO2008060705A3 (en) Anti-dll4 antibodies and methods using same
WO2007136893A3 (en) Anti-fgf19 antibodies and methods using same
WO2006079076A3 (en) Yersinia spp. polypeptides and methods of use
WO2006060513A3 (en) Toll like receptor 3 antagonists, methods and uses
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
WO2007051164A8 (en) Toll like receptor 3 modulators, methods and uses
WO2009058564A3 (en) Immunosuppressive polypeptides and nucleic acids
EP1578930A4 (en) Cngh0004 polypeptides, antibodies, compositions, methods and uses
WO2006063028A3 (en) Immunostimulatory compositions and uses thereof
WO2007053512A3 (en) Novel protein transduction domains and uses therefor
WO2007073554A3 (en) Block copolymer particles
WO2005047545A3 (en) Microarray controls
WO2006088803A3 (en) Polypeptides from staphylococcus aureus and methods of use
WO2007127506A3 (en) Anti-ephrinb2 antibodies and methods using same
WO2006091848A3 (en) Isolated bis-linezolid, preparation thereof, and its use as a reference standard
EP1617802A4 (en) Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses.
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2006050458A3 (en) Tadalafil crystal forms and processes for preparing them
TW200700085A (en) Endoparasiticidal compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 10588627

Country of ref document: US